Buchberger, B <br/><br/>
The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA).  [electronic resource] 

 -  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  Sep 2011 
 - 472-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1439-3646 
<br/><br/><label>Standard No.: </label>10.1055/s-0031-1279713  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Combined Modality Therapy<br/>Diabetic Foot--drug therapy<br/>Epidermal Growth Factor--adverse effects<br/>Evidence-Based Medicine<br/>Fibroblast Growth Factors--adverse effects<br/>Humans<br/>Platelet-Derived Growth Factor--adverse effects<br/>Recombinant Proteins--adverse effects<br/>Skin, Artificial--adverse effects<br/>Technology Assessment, Biomedical